$61.53 $0.03 (0.0%)

01:58 PM EDT on 06/02/20

NuVasive, Inc. (NASDAQ:NUVA)

CAPS Rating: 3 out of 5

A medical device company focused on the design, development and marketing of products for the surgical treatment of spine disorders.

Current Price $61.53 Mkt Cap $3.2B
Open $62.11 P/E Ratio 52.30
Prev. Close $61.50 Div. (Yield) $0.00 (0.0%)
Daily Range $60.47 - $62.11 Volume 385,908
52-Wk Range $28.55 - $81.91 Avg. Daily Vol. 957,486

Caps

How do you think NASDAQ:NUVA will perform against the market?

Add Stock to CAPS Watchlist

All Players

227 Outperform
18 Underperform
 

All-Star Players

60 Outperform
5 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Recent Community Commentary

Read the most recent pitches from players about NUVA.

Recs

0
Member Avatar Engineer123 (< 20) Submitted: 10/25/2018 4:33:06 AM : Outperform Start Price: $62.65 NASDAQ:NUVA Score: -16.03

Yes, ceo changes will improve company performance.com

Recs

0
Member Avatar wadethefred (77.19) Submitted: 6/10/2018 11:50:30 AM : Outperform Start Price: $53.00 NASDAQ:NUVA Score: +6.52

While top line growth is solid it is declining. However, international sales is booming. Yes, competition is heating up and margins are being squeezed, but future prospects are still bright and now at 35% off their high, I'm betting NuVasive outperforms the market. An aging baby boomer population should help the whole industry.

Recs

0
Member Avatar XMFRendezvous (94.72) Submitted: 4/23/2018 2:45:25 AM : Outperform Start Price: $53.00 NASDAQ:NUVA Score: +1.91

They have a niche market cornered and are only trading at 21x forward P/E

Leaderboard

Find the members with the highest scoring picks in NUVA.

Score Leader

TrackPoisedTo

TrackPoisedTo (< 20) Score: +297.15

The Score Leader is the player with the highest score across all their picks in NUVA.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
cdbell1114 < 20 10/9/2012 Outperform 3Y $14.34 +331.59% +110.95% +220.64 0 Comment
marketbuyer < 20 11/22/2011 Outperform 5Y $12.99 +376.44% +157.56% +218.88 0 Comment
redfox18 99.90 10/4/2012 9/14/2017 Outperform 3Y $15.02 +312.05% +110.84% +201.21 0 Comment
TMFRSue < 20 10/4/2012 Outperform 3Y $15.02 +312.05% +110.98% +201.08 1 Comment
KYSO 41.30 12/14/2012 Outperform 5Y $15.00 +312.60% +115.70% +196.90 0 Comment
anticitradeshort 28.93 4/20/2009 Underperform NS $29.90 +106.99% +262.62% +155.63 0 Comment
sniggity 41.60 1/30/2013 Outperform 5Y $17.66 +250.45% +103.79% +146.66 0 Comment
AllMagic < 20 1/9/2013 Outperform 3M $17.37 +256.30% +110.58% +145.72 0 Comment
neoap 57.99 1/10/2013 Outperform 5Y $17.68 +250.06% +109.22% +140.84 0 Comment
schwah5 75.76 7/30/2008 Underperform NS $54.97 +12.59% +149.35% +136.76 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for NUVA.